The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 03, 2023

Filed:

Aug. 15, 2018
Applicant:

Bhl Patent Holdings Llc, Towanda, PA (US);

Inventor:

Bruce H Levin, Philadelphia, PA (US);

Assignee:

BHL PATENT HOLDINGS LLC, Towanda, PA (US);

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61N 1/36 (2006.01); A61N 1/04 (2006.01); A61N 1/378 (2006.01); A61K 31/445 (2006.01); A61P 29/00 (2006.01); A61P 25/06 (2006.01); A61P 25/02 (2006.01); A61K 31/167 (2006.01); A61M 19/00 (2006.01); A61M 11/00 (2006.01); A61M 15/08 (2006.01);
U.S. Cl.
CPC ...
A61N 1/36071 (2013.01); A61K 31/167 (2013.01); A61K 31/445 (2013.01); A61M 19/00 (2013.01); A61N 1/0484 (2013.01); A61N 1/36021 (2013.01); A61N 1/3787 (2013.01); A61P 25/02 (2018.01); A61P 25/06 (2018.01); A61P 29/00 (2018.01); A61M 11/007 (2014.02); A61M 15/08 (2013.01); A61M 2202/048 (2013.01); A61M 2210/0618 (2013.01); A61N 1/36139 (2013.01);
Abstract

Methods, apparatus, compositions and kits for inhibiting a disorder in a human patient, including non-cerebral neurovascular disorder or muscular headache pain, or loss of motor or sensory function, sympathetic tone or range or fluidity of motion that affect a nerve pathway at more than one locus associated with the disorder to inhibit the disorder. Alternatively or in addition, neuropathy associated with a disorder is treatable by palpating to determine a Keystone nerve essential to the neuropathy, applying pressure to determine a point of maximum discomfort or trigger of increased symptoms to identify a Levin Sign as a locus of initial intervention, and intervening to treat the neuropathy at the location of the Levin Sign by administering a pharmaceutically active agent, internal implanted or external neuro stimulation affecting the nerve pathway to inhibit the neuropathy.


Find Patent Forward Citations

Loading…